Shareholder Update: December 2011

In this issue:

› Starpharma raises $35m to advance pipeline

› Starpharma signs with Ansell for condom coating

› Putting a stop to stubborn BV: The VivaGel^© solution

› Clinical trials for VivaGel^© gather pace

› M&G invests $20 million

› Dendrimers through the eyes of Professor Donald Tomalia

Download: Shareholder Update: December 2011 (pdf file, 628kb)